SCHEMBL31747839

SCHEMBL31747839

Cc1cc(C(C)(C)C)c(C(F)(F)F)cc1-c1cc(=O)c([S@@](C)(=N)=O)c(C)[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31747928 1.00 — —
SCHEMBL31747969 1.00 — —
SCHEMBL26601580 0.91 MAPK1 (0.33) —
SCHEMBL26601575 0.85 — —
SCHEMBL26601571 0.85 — —
SCHEMBL26601569 0.85 — —
SCHEMBL30624589 0.80 SCN9A (0.30) —
SCHEMBL31747808 0.80 SCN9A (0.30) —
SCHEMBL26698083 0.80 SCN9A (0.30) —
SCHEMBL26601787 0.80 SCN9A (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250388541-A1 HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN VERTEX PHARMACEUTICALS INCORPORATED (US) 2025-12-25 — — US disclosed
Send feedback